194 related articles for article (PubMed ID: 38025726)
1. FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma.
Liao Q; Yang J; Lu Z; Jiang Q; Gong Y; Liu L; Peng H; Wang Q; Zhang X; Liu Z
PeerJ; 2023; 11():e16493. PubMed ID: 38025726
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
3. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2.
Wang X; Li Y; Pan M; Lu T; Wang M; Wang Z; Liu C; Hu G
Clin Sci (Lond); 2022 Nov; 136(22):1691-1710. PubMed ID: 36377775
[TBL] [Abstract][Full Text] [Related]
4. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
Wen Z; Zhang Y; Gao B; Chen X
J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma.
Mao W; Ding J; Li Y; Huang R; Wang B
Exp Ther Med; 2022 Aug; 24(2):521. PubMed ID: 35837069
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
7. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
9. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.
Li J; Xiao W; Wei W; Wu M; Xiong K; Lyu J; Li Y
Mol Immunol; 2023 Jun; 158():79-90. PubMed ID: 37172353
[TBL] [Abstract][Full Text] [Related]
10. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma.
Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H
Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576
[TBL] [Abstract][Full Text] [Related]
12. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma.
Zhang H; Yin X; Zhang X; Zhou M; Xu W; Wei Z; Song C; Han S; Han W
Technol Cancer Res Treat; 2022; 21():15330338221118202. PubMed ID: 35929142
[No Abstract] [Full Text] [Related]
13. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
[TBL] [Abstract][Full Text] [Related]
14. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylated SPANXA1/A2 promotes the metastasis of head and neck squamous cell carcinoma.
Li J; Bo H; Zhu F; Li Q; Chen T; Lei S; Fan L
Med Oncol; 2020 Nov; 37(12):112. PubMed ID: 33175201
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
18. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
Li B; Zhu J; Meng L
Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
[TBL] [Abstract][Full Text] [Related]
19. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
[TBL] [Abstract][Full Text] [Related]
20. CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
Zhang MJ; Liu J; Wan SC; Li JX; Wang S; Fidele NB; Huang CF; Sun ZJ
Head Neck; 2023 Sep; 45(9):2161-2172. PubMed ID: 37466293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]